COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 344: Articles 3431-3440  | Next

SPLASH: a statistical, reference-free genomic algorithm unifies biological discovery
Chaung, K., Baharav, T. Z., Henderson, G., Wang, P., Zheludev, I. N., Salzman, J.
10.1101/2023.07.17.549408 — Posted: 2023-07-18
ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys
Fenwick, C., Turelli, P., Duhoo, Y., Lau, K., Herate, C., Marlin, R., Lamrayah, M., Campos, J., Leuenberger, L., Farina, A., raclot, c., Genet, V., Fiscalini, F., Cesborn, J., Perez, L., Bosquet, N., Contreras, V., Lheureux, K., relouzat, f., Abdelnabi, R., Foo, C. S.-Y., Neyts, J., leyssen, p., Levy, Y., Pojer, F., Stahlberg, H., Le Grand, R., Trono, D., Pantaleo, G.
10.1101/2023.07.18.549530 — Posted: 2023-07-18
Deep mutational scanning of whole SARS-CoV-2 spike in an inverted infection system
Taminishi, S., Li, S., Higuchi, Y., Kirita, Y., Motooka, D., Ozaki, Y., Arimori, T., Ikemura, N., Ito, Y., Matoba, S., Okamoto, T., Takagi, J., Standley, D. M., Hoshino, A.
10.1101/2023.07.17.549430 — Posted: 2023-07-18
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages
Li, L., Chen, X., Wang, Z., Li, Y., Wang, C., Jiang, L., Zuo, T.
10.1101/2023.07.18.549524 — Posted: 2023-07-18
Pharmacological Evaluations of Select Herbal Extracts on TLR7/8-induced Cytokine and Chemokine Production in Macrophage-like Cells
Dagar, M., Priya, K., Dikshit, M., Kumar, A.
10.1101/2023.07.16.549251 — Posted: 2023-07-18
Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2
Hilligan, K. L., Namasivayam, S., Clancy, C. S., Baker, P. J., Old, S. I., Peluf, V., Amaral, E. P., Oland, S. D., O'Mard, D., Laux, J., Cohen, M., Garza, N. L., Lafont, B., Johnson, R. F., Feng, C. G., Jankovic, D., Lamiable, O., Mayer-Barber, K. D., Sher, A.
10.1101/2023.07.15.549135 — Posted: 2023-07-17
Using big sequencing data to identify chronic SARS-Coronavirus-2 infections
Harari, S., Miller, D., Fleishon, S., Burstein, D., Stern, A.
10.1101/2023.07.16.549184 — Posted: 2023-07-17
Megakaryocyte infection by SARS-CoV-2 drives the formation of pathogenic afucosylated IgG antibodies in mice
Mabrouk, M., Jalali, F., Zaid, N., Naya, A., Khyatti, M., Khalki, L., Guessous, F., Zaid, Y.
10.1101/2023.07.14.549113 — Posted: 2023-07-17
Causal association of COVID-19 with brain structure changes: Findings from a non-overlapping 2-sample Mendelian randomization study
Ding, P., Xu, R.
10.1101/2023.07.16.23292735 — Posted: 2023-07-17
Deep spatial proteomic exploration of severe COVID-19-related pulmonary injury in post-mortem specimens
Mao, Y., Chen, Y., Li, Y., Ma, L., Wang, X., Wang, Q., He, A., Liu, X., Dong, T., Gao, W., Xu, Y., Liu, L., Ren, L., Liu, Q., Zhou, P., Hu, B., Zhou, Y., Tian, R., Shi, Z.-L.
10.1101/2023.07.14.548971 — Posted: 2023-07-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).